Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

ATRA and ATO can induce remission in NPM1-mutated AML: First clinical report of a chemo-free strategy

Matheus Puls, Caio Prato, Thales Pereira, Clarissa Melo, Pedro Flores, Jamilla Cavalcante, Lucas Lanza, Patricia Yamamoto, Lucas Silva, Maria Cristina Macedo, Roberto Silva

Blood (2025) 146 (Supplement 1): 6978.

https://doi.org/10.1182/blood-2025-6978

Published: 2025

Journal Articles

Haploidentical hematopoietic stem cell transplantation with bussulfan, fludarabine and cyclophosphamide and total body irradiation 200cgy conditioning with post-transplant cyclophosphamide and peripheral blood stem cells as an alternative regimen to reduce graft rejection in sickle cell disease

Roberto Silva, Lucas Silva, Clarissa Melo, Ana Macedo, Rebecca Tenorio, Caio Prato, Thales Pereira, Matheus Puls, Jamilla Cavalcante, Patricia Yamamoto, Pedro Flores, Lucas Lanza, Maria Cristina Macedo

Blood (2025) 146 (Supplement 1): 7724.

https://doi.org/10.1182/blood-2025-7724

Published: 2025

Journal Articles

Concomitant use of venetoclax 100 mg and ketoconazole, a strong CYP3A4 inhibitor, is clinically equivalent to venetoclax 400 mg for treating relapsed or refractory chronic lymphocytic leukemia (CLL): A real-world analysis from the brazilian CLL registry.“

Gabriel Cunha, Pedro Perez, Fernanda Marques, Verena Pfister, Rodrigo Santucci, Milton Aranha, Danielle De Farias, Talita Silveira, Jayr Schmidt Filho, Valeria Buccheri, Roberto Silva, Leila Perobelli, Glaciano Ribeiro, Maura Colturato, Nelson Hamerschlak, Pedro Fernandes, Fernanda Santos Azevedo, Carlos Chiattone, Celso Arrais-Rodrigues

Blood (2025) 146 (Supplement 1): 3909.

https://doi.org/10.1182/blood-2025-3909

Published: 2025

Journal Articles

Retroperitoneal hemorrhage following a bone marrow biopsy

Krishna Gundabolu, Roberto Silva Aguiar

Blood (2021) 138 (14): 1283.

https://doi.org/10.1182/blood.2021011319

Published: 2021

Journal Articles

Fertility Outcomes after Allogeneic Hematopoietic Stem Cell Transplants Conditioned with Busulfan 4 Mg/Kg and Cyclophosphamide 200 Mg/Kg to Treat Severe Aplastic Anemia

Mariana Nassif Kerbauy, MD, Livia Caroline Barbosa Mariano, MD, Erick Menezes, MD, Evandro Dantas, MD, Jayr Schmidt Sobrinho, MD, Marina M Nascimento, MD, Roberto Silva, MD, Maria Cristina Macedo, MD, Sandra Gualandro, MD PhD, Adriana Seber, MD MS

Blood (2015) 126 (23): 4460.

https://doi.org/10.1182/blood.V126.23.4460.4460

Published: 2015

Journal Articles

Successful Treatment of Pure Red Cell Aplasia after Major ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia with Repeated Doses of the Single-Agent Rituximab: A Case Report.

Karla O. Mota, MD, Maria Cristina Macedo, MD, Roberto Silva, MD

Blood (2007) 110 (11): 4934.

https://doi.org/10.1182/blood.V110.11.4934.4934

Published: 2007

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

ATRA and ATO can induce remission in NPM1-mutated AML: First clinical report of a chemo-free strategy

Haploidentical hematopoietic stem cell transplantation with bussulfan, fludarabine and cyclophosphamide and total body irradiation 200cgy conditioning with post-transplant cyclophosphamide and peripheral blood stem cells as an alternative regimen to reduce graft rejection in sickle cell disease

Concomitant use of venetoclax 100 mg and ketoconazole, a strong CYP3A4 inhibitor, is clinically equivalent to venetoclax 400 mg for treating relapsed or refractory chronic lymphocytic leukemia (CLL): A real-world analysis from the brazilian CLL registry.“

Retroperitoneal hemorrhage following a bone marrow biopsy

Fertility Outcomes after Allogeneic Hematopoietic Stem Cell Transplants Conditioned with Busulfan 4 Mg/Kg and Cyclophosphamide 200 Mg/Kg to Treat Severe Aplastic Anemia

Successful Treatment of Pure Red Cell Aplasia after Major ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia with Repeated Doses of the Single-Agent Rituximab: A Case Report.

Email alerts

ASH Publications

American Society of Hematology

Update search

ATRA and ATO can induce remission in NPM1-mutated AML: First clinical report of a chemo-free strategy

Haploidentical hematopoietic stem cell transplantation with bussulfan, fludarabine and cyclophosphamide and total body irradiation 200cgy conditioning with post-transplant cyclophosphamide and peripheral blood stem cells as an alternative regimen to reduce graft rejection in sickle cell disease

Concomitant use of venetoclax 100 mg and ketoconazole, a strong CYP3A4 inhibitor, is clinically equivalent to venetoclax 400 mg for treating relapsed or refractory chronic lymphocytic leukemia (CLL): A real-world analysis from the brazilian CLL registry.“

Retroperitoneal hemorrhage following a bone marrow biopsy

Fertility Outcomes after Allogeneic Hematopoietic Stem Cell Transplants Conditioned with Busulfan 4 Mg/Kg and Cyclophosphamide 200 Mg/Kg to Treat Severe Aplastic Anemia

Successful Treatment of Pure Red Cell Aplasia after Major ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia with Repeated Doses of the Single-Agent Rituximab: A Case Report.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only